Search
Search
Preimplantation Genetic Testing for Monogenic/Single-Gene Disorders (PGT-M) is widely used in reproductive genetics research to investigate inherited variants in embryos generated through in-vitro fertilization (IVF). In research settings, PGT-M workflows enable the study of variant inheritance, haplotyping strategies, and assay performance for detecting disease-associated mutations.
In collaboration with Journey Genomics, S.L., Thermo Fisher Scientific provides a targeted next-generation sequencing (NGS) workflow based on Ion Torrent technology and PGD-SEQ research panels to support method development, workflow evaluation, and assay verification in research laboratories.
Targeted next-generation sequencing (NGS) is a technology for preimplantation genetic testing for monogenic disorders (PGT-M), enabling accurate detection of single-gene variants and high-resolution haplotype analysis across defined genomic regions.
With targeted NGS, researchers can:
PGD-SEQ* kits are targeted amplification solutions designed for preimplantation genetic testing of monogenic/single-gene disorders (PGT-M) in research workflows. PGD-SEQ kits offer over 500 gene panels to support investigation of embryo genetic status across both common and rare inherited conditions in IVF research.
Developed in collaboration with Journey Genomics, S.L., and powered by Ion Torrent next-generation sequencing (NGS) technology, PGD-SEQ enables a single research sample to be used for both PGT-A and PGT-M investigations within a simplified and integrated workflow.
PGD-SEQ panels are used in reproductive genetics research to:
PGD-SEQ kits enable comprehensive familial assessment using proprietary linkage analysis software. SNP markers flanking regions of interest allow researchers to construct haplotypes and track inheritance patterns, supporting robust evaluation of variant transmission in research studies.
Combine the PGD-SEQ kit with Ion ReproSeq PGS kit using the Ion GeneStudio S5 System for a simple, scalable and automated sample-to-answer workflow solution that includes PGT-M and PGT-A results from single research sample.
Service and support for the PGD-SEQ kits, design and software analysis are provided by our partner, Journey Genomics, S.L.
Support for Ion Torrent sequencers is provided by the Thermo Fisher Scientific team. To learn more about service and support for Ion Torrent reproductive health assays, visit our dedicated page.
PGD-SEQ research panels are targeted amplification panels designed for use in PGT-M research workflows. They enable amplification of disease-associated loci and informative SNP markers to support variant detection and haplotyping studies.
PGD-SEQ panels include SNP markers flanking regions of interest, enabling researchers to perform linkage analysis and construct haplotypes for tracking inheritance patterns in research studies.
Yes, PGD-SEQ research panels support customization to target specific genes, variants, and SNP markers relevant to particular research applications or study designs.
PGD-SEQ panels are designed for use with low-input DNA samples, including whole genome amplified (WGA) DNA derived from embryo biopsy material, as well as parental or reference DNA for linkage analysis.
PGD-SEQ panels are used for targeted amplification prior to sequencing on Ion GeneStudio systems. The resulting data can be analyzed using the included Journey Genomics’ PGD-SEQ software to evaluate variant detection and haplotyping performance.
*PGD-SEQ is a trademark of Journey Genomics, S.L.
For Research Use Only. Not for use in diagnostic procedures.
PMR: 004035